{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:30:42Z","timestamp":1792657842578,"version":"4.5.0"},"reference-count":115,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004515","name":"Universiti Kebangsaan Malaysia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004515","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Translational Medicine"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.retram.2019.09.001","type":"journal-article","created":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T08:26:22Z","timestamp":1568881582000},"page":"5-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"title":["Characteristics and clinical applications of Wharton\u2019s jelly-derived mesenchymal stromal cells"],"prefix":"10.1016","volume":"68","author":[{"given":"L.L.","family":"Liau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.H.I.","family":"Ruszymah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.H.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9045-5145","authenticated-orcid":false,"given":"J.X.","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.retram.2019.09.001_bib0005","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2147\/ciia.2007.2.1.93","article-title":"A review of a bi-layered living cell treatment (Apligraf\u00ae) in the treatment of venous leg ulcers and diabetic foot ulcers","volume":"2","author":"Zaulyanov","year":"2007","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.retram.2019.09.001_bib0010","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/382530","article-title":"Applications of induced pluripotent stem cells in studying the neurodegenerative diseases","volume":"2015","author":"Wan","year":"2015","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.retram.2019.09.001_bib0015","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.retram.2019.09.001_bib0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1479-5876-9-29","article-title":"Risk factors in the development of stem cell therapy","volume":"9","author":"Herberts","year":"2011","journal-title":"J Transl Med"},{"key":"10.1016\/j.retram.2019.09.001_bib0025","doi-asserted-by":"crossref","DOI":"10.1007\/s13770-019-00196-w","article-title":"Current progress in tendon and ligament tissue engineering","author":"Lim","year":"2019","journal-title":"Tissue Eng Regen Med"},{"key":"10.1016\/j.retram.2019.09.001_bib0030","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/icb.2012.64","article-title":"Immunological characteristics of human mesenchymal stem cells and multipotent adult progenitor cells","volume":"91","author":"Jacobs","year":"2013","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.retram.2019.09.001_bib0035","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/stem.2475","article-title":"Allogeneic mesenchymal stem cells stimulate cartilage regeneration and are safe for single-stage cartilage repair in humans upon mixture with recycled autologous chondrons","volume":"35","author":"de Windt","year":"2017","journal-title":"Stem Cells"},{"key":"10.1016\/j.retram.2019.09.001_bib0040","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s12015-012-9418-z","article-title":"The therapeutic potential, challenges and future clinical directions of stem cells from the Wharton\u2019s jelly of the human umbilical cord","volume":"9","author":"Bongso","year":"2013","journal-title":"Stem Cell Rev Reports"},{"key":"10.1016\/j.retram.2019.09.001_bib0045","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s13770-017-0086-6","article-title":"Mesenchymal stromal cells from the maternal segment of human umbilical cord is ideal for bone regeneration in allogenic setting","volume":"15","author":"Lim","year":"2018","journal-title":"Tissue Eng Regen Med"},{"key":"10.1016\/j.retram.2019.09.001_bib0050","doi-asserted-by":"crossref","first-page":"580","DOI":"10.4236\/jbise.2012.510071","article-title":"Mixed enzymatic-explant protocol for isolation of mesenchymal stem cells from Wharton\u2019s jelly and encapsulation in 3D culture system","volume":"5","author":"Azandeh","year":"2012","journal-title":"J Biomed Sci Eng"},{"key":"10.1016\/j.retram.2019.09.001_bib0055","first-page":"243","article-title":"Mesenchymal stem cells derived from Wharton\u2019s jelly: comparative phenotype analysis between tissue and in vitro expansion","volume":"22","author":"Margossian","year":"2012","journal-title":"Biomed Mater Eng"},{"key":"10.1016\/j.retram.2019.09.001_bib0060","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/428726","article-title":"Comparison of explant-derived and enzymatic digestion-derived MSCs and the growth factors from Wharton\u2019s jelly","volume":"2013","author":"Yoon","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.retram.2019.09.001_bib0065","first-page":"28","article-title":"Wharton\u2019s jelly derived-mesenchymal stem cells: isolation and characterization","author":"Ranjbaran","year":"2018","journal-title":"Acta Med Iran"},{"key":"10.1016\/j.retram.2019.09.001_bib0070","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.retram.2019.09.001_bib0075","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.1007\/s11033-010-0665-2","article-title":"Replicative senescence of human bone marrow and umbilical cord derived mesenchymal stem cells and their differentiation to adipocytes and osteoblasts","volume":"38","author":"Cheng","year":"2011","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.retram.2019.09.001_bib0080","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1089\/scd.2010.0589","article-title":"Evaluation of senescence in mesenchymal stem cells isolated from equine bone marrow, adipose tissue, and umbilical cord tissue","volume":"21","author":"Vidal","year":"2011","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.retram.2019.09.001_bib0085","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/21645515.2015.1030549","article-title":"Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton\u2019s jelly as sources of cell immunomodulatory therapy","volume":"12","author":"Wang","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.retram.2019.09.001_bib0090","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3892\/ijmm.2014.1821","article-title":"Comprehensive characterization of four different populations of human mesenchymal stem cells as regards their immune properties, proliferation and differentiation","volume":"34","author":"Li","year":"2014","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.retram.2019.09.001_bib0095","doi-asserted-by":"crossref","first-page":"365","DOI":"10.18388\/abp.2016_1488","article-title":"Osteogenic differentiation of human mesenchymal stem cells from adipose tissue and Wharton\u2019s jelly of the umbilical cord","volume":"64","author":"Zajdel","year":"2017","journal-title":"Acta Biochim Pol"},{"key":"10.1016\/j.retram.2019.09.001_bib0100","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1089\/scd.2009.0485","article-title":"Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton\u2019s jelly of umbilical cord","volume":"19","author":"Hsieh","year":"2010","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.retram.2019.09.001_bib0105","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1089\/ten.tea.2008.0393","article-title":"A comparison of human bone marrow\u2013derived mesenchymal stem cells and human umbilical cord\u2013derived mesenchymal stromal cells for cartilage tissue engineering","volume":"15","author":"Wang","year":"2009","journal-title":"Tissue Eng Part A"},{"key":"10.1016\/j.retram.2019.09.001_bib0110","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.jcyt.2015.09.007","article-title":"The effect of fibroblast growth factor on distinct differentiation potential of cord blood\u2013derived unrestricted somatic stem cells and Wharton\u2019s jelly\u2013derived mesenchymal stem\/stromal cells","volume":"17","author":"Lee","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1016\/j.retram.2019.09.001_bib0115","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.jcyt.2016.08.003","article-title":"MSCs can be differentially isolated from maternal, middle and fetal segments of the human umbilical cord","volume":"18","author":"Lim","year":"2016","journal-title":"Cytotherapy"},{"key":"10.1016\/j.retram.2019.09.001_bib0120","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00441-017-2699-4","article-title":"Comparative analysis of human Wharton\u2019s jelly mesenchymal stem cells derived from different parts of the same umbilical cord","volume":"372","author":"Bharti","year":"2018","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.retram.2019.09.001_bib0125","first-page":"89","article-title":"Intrauterine xenotransplantation of human Wharton jelly-derived mesenchymal stem cells into the liver of rabbit fetuses: a preliminary study for in vivo expression of the human liver genes","volume":"21","author":"Rezaeian","year":"2018","journal-title":"Iran J Basic Med Sci"},{"key":"10.1016\/j.retram.2019.09.001_bib0130","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1089\/scd.2009.0177","article-title":"Long-term expansion and pluripotent marker array analysis of Wharton\u2019s jelly-derived mesenchymal stem cells","volume":"19","author":"Nekanti","year":"2010","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.retram.2019.09.001_bib0135","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.exphem.2009.02.003","article-title":"Endothelial differentiation of Wharton\u2019s jelly\u2013derived mesenchymal stem cells in comparison with bone marrow\u2013derived mesenchymal stem cells","volume":"37","author":"Chen","year":"2009","journal-title":"Exp Hematol"},{"key":"10.1016\/j.retram.2019.09.001_bib0140","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/306158","article-title":"Comparisons of differentiation potential in human mesenchymal stem cells from Wharton\u2019s jelly, bone marrow, and pancreatic tissues","volume":"2015","author":"Kao","year":"2015","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.retram.2019.09.001_bib0145","first-page":"12","article-title":"Comparison of mesenchymal stem cells derived from fat, bone marrow, Wharton\u2019s jelly, and umbilical cord blood for treating spinal cord injuries in dogs","author":"Ryu","year":"2012","journal-title":"J Vet Med Sci"},{"key":"10.1016\/j.retram.2019.09.001_bib0150","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/cbin.10056","article-title":"Higher propensity of Wharton\u2019s jelly derived mesenchymal stromal cells towards neuronal lineage in comparison to those derived from adipose and bone marrow","volume":"37","author":"Balasubramanian","year":"2013","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.retram.2019.09.001_bib0155","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1089\/scd.2018.0132","article-title":"Human Wharton\u2019s jelly mesenchymal stem cells show unique gene expression compared with bone marrow mesenchymal stem cells using single-cell RNA-sequencing","volume":"28","author":"Barrett","year":"2018","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.retram.2019.09.001_bib0160","first-page":"145","article-title":"Growth suppression effect of human mesenchymal stem cells from bone marrow, adipose tissue, and Wharton\u2019s jelly of umbilical cord on PBMCs","volume":"19","author":"Ayatollahi","year":"2016","journal-title":"Iran J Basic Med Sci"},{"key":"10.1016\/j.retram.2019.09.001_bib0165","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/583984","article-title":"What makes umbilical cord tissue-derived mesenchymal stromal cells superior immunomodulators when compared to bone marrow derived mesenchymal stromal cells?","volume":"2015","author":"Barcia","year":"2015","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.retram.2019.09.001_bib0170","doi-asserted-by":"crossref","first-page":"687","DOI":"10.7603\/s40730-016-0029-1","article-title":"Umbilical cord-derived stem cells (MODULATISTTM) show strong immunomodulation capacity compared to adipose tissue-derived or bone marrow-derived mesenchymal stem cells","volume":"3","author":"Van Pham","year":"2016","journal-title":"Biomed Res Ther"},{"key":"10.1016\/j.retram.2019.09.001_bib0175","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cellimm.2010.06.006","article-title":"Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: combined comparison of adipose tissue, Wharton\u2019s Jelly and bone marrow sources","volume":"264","author":"Najar","year":"2010","journal-title":"Cell Immunol"},{"key":"10.1016\/j.retram.2019.09.001_bib0180","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.intimp.2013.02.020","article-title":"Impact of different mesenchymal stromal cell types on T-cell activation, proliferation and migration","volume":"15","author":"Najar","year":"2013","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.retram.2019.09.001_bib0185","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/scrt336","article-title":"Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells","volume":"4","author":"Ribeiro","year":"2013","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.retram.2019.09.001_bib0190","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cellimm.2012.06.010","article-title":"Immune characterization of mesenchymal stem cells in human umbilical cord Wharton\u2019s jelly and derived cartilage cells","volume":"278","author":"Liu","year":"2012","journal-title":"Cell Immunol"},{"key":"10.1016\/j.retram.2019.09.001_bib0195","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1634\/stemcells.2007-1028","article-title":"Immune properties of human umbilical cord Wharton\u2019s jelly-derived cells","volume":"26","author":"Weiss","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.retram.2019.09.001_bib0200","first-page":"101","article-title":"Study on immunomodulatory properties of human umbilical cord mesenchymal stem cells after osteogenic differentiation","volume":"3","author":"Syazzuan","year":"2014","journal-title":"Regen Res"},{"key":"10.1016\/j.retram.2019.09.001_bib0205","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s13287-018-1078-8","article-title":"Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review","volume":"9","author":"Christodoulou","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.retram.2019.09.001_bib0210","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/09553002.2018.1400191","article-title":"Significant expression of tafazzin (TAZ) protein in colon cancer cells and its downregulation by radiation","volume":"94","author":"Pathak","year":"2018","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.retram.2019.09.001_bib0215","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1097\/TP.0b013e31821aba18","article-title":"Effective treatment of severe steroid-resistant acute graft-versus-host disease with umbilical cord-derived mesenchymal stem cells","volume":"91","author":"Wu","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.retram.2019.09.001_bib0220","first-page":"303","article-title":"Clinical study of umbilical cord-derived mesenchymal stem cells for treatment of nineteen patients with steroid-resistant severe acute graft-versus-host disease","volume":"33","author":"Chen","year":"2012","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.retram.2019.09.001_bib0225","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3906\/biy-1508-47","article-title":"Third-party Wharton\u2019s jelly mesenchymal stem cells for treatment of steroid-resistant acute and chronic graft-versus-host disease: a report of 10 cases","volume":"40","author":"Boruczkowski","year":"2016","journal-title":"Turk J Biol"},{"key":"10.1016\/j.retram.2019.09.001_bib0230","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.livres.2017.07.001","article-title":"Mesenchymal stem cells for treatment of steroid-resistant acute rejection after liver transplantation","volume":"1","author":"Zhang","year":"2017","journal-title":"Liver Res"},{"key":"10.1016\/j.retram.2019.09.001_bib0235","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000362530","article-title":"Mesenchymal stromal cells as an adjuvant treatment for severe late-onset hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation","volume":"133","author":"Wang","year":"2015","journal-title":"Acta Haematol"},{"key":"10.1016\/j.retram.2019.09.001_bib0240","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.2337\/dc10-S062","article-title":"Diagnosis and classification of diabetes mellitus","volume":"33","author":"Association AD","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.retram.2019.09.001_bib0245","doi-asserted-by":"crossref","first-page":"841","DOI":"10.15252\/embj.201490685","article-title":"Toward beta cell replacement for diabetes","volume":"34","author":"Johannesson","year":"2015","journal-title":"EMBO J"},{"key":"10.1016\/j.retram.2019.09.001_bib0250","doi-asserted-by":"crossref","first-page":"e1451","DOI":"10.1371\/journal.pone.0001451","article-title":"Islet-like clusters derived from mesenchymal stem cells in Wharton\u2019s Jelly of the human umbilical cord for transplantation to control type 1 diabetes","volume":"3","author":"Chao","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.retram.2019.09.001_bib0255","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1423-0127-19-47","article-title":"Transplantation of insulin-producing cells from umbilical cord mesenchymal stem cells for the treatment of streptozotocin-induced diabetic rats","volume":"19","author":"Tsai","year":"2012","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.retram.2019.09.001_bib0260","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1507\/endocrj.EJ12-0343","article-title":"Long term effects of the implantation of Wharton\u2019s jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus","volume":"60","author":"Hu","year":"2013","journal-title":"Endocr J"},{"key":"10.1016\/j.retram.2019.09.001_bib0265","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/scrt446","article-title":"A preliminary evaluation of efficacy and safety of Wharton\u2019s jelly mesenchymal stem cell transplantation in patients with type 2 diabetes mellitus","volume":"5","author":"Liu","year":"2014","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.retram.2019.09.001_bib0270","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.3892\/etm.2015.2339","article-title":"Therapeutic efficacy of umbilical cord-derived mesenchymal stem cells in patients with type 2 diabetes","volume":"9","author":"Guan","year":"2015","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.retram.2019.09.001_bib0275","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.3892\/etm.2016.3544","article-title":"Long term effect and safety of Wharton\u2019s jelly-derived mesenchymal stem cells on type 2 diabetes","volume":"12","author":"Hu","year":"2016","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.retram.2019.09.001_bib0280","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1089\/scd.2009.0299","article-title":"New emerging potentials for human Wharton\u2019s jelly mesenchymal stem cells: immunological features and hepatocyte-like differentiative capacity","volume":"19","author":"Anzalone","year":"2010","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.retram.2019.09.001_bib0285","first-page":"106","article-title":"Retinoic acid as the stimulating factor for differentiation of Wharton\u2019s Jelly-Mesenchymal stem cells into hepatocyte-like cells","volume":"7","author":"Mortezaee","year":"2015","journal-title":"Avicenna J Med Biotechnol"},{"key":"10.1016\/j.retram.2019.09.001_bib0290","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1478-3231.2008.01855.x","article-title":"Mesenchymal stem cells from human umbilical cords ameliorate mouse hepatic injury in vivo","volume":"29","author":"Yan","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.retram.2019.09.001_bib0295","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1053\/j.gastro.2007.12.024","article-title":"Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells","volume":"134","author":"Campard","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.retram.2019.09.001_bib0300","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/lt.21715","article-title":"The therapeutic potential of human umbilical mesenchymal stem cells from Wharton\u2019s jelly in the treatment of rat liver fibrosis","volume":"15","author":"Tsai","year":"2009","journal-title":"Liver Transplant"},{"key":"10.1016\/j.retram.2019.09.001_bib0305","doi-asserted-by":"crossref","first-page":"725","DOI":"10.5966\/sctm.2012-0034","article-title":"Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients","volume":"1","author":"Shi","year":"2012","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.retram.2019.09.001_bib0310","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/jgh.12029","article-title":"A pilot study of umbilical cord\u2010derived mesenchymal stem cell transfusion in patients with primary biliary cirrhosis","volume":"28","author":"Wang","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.retram.2019.09.001_bib0315","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1440-1746.2011.07024.x","article-title":"Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients","volume":"27","author":"Zhang","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.retram.2019.09.001_bib0320","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/1756-185X.13015","article-title":"Effects of allogeneic mesenchymal stem cell transplantation in the treatment of liver cirrhosis caused by autoimmune diseases","volume":"20","author":"Liang","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.retram.2019.09.001_bib0325","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.clinre.2017.11.003","article-title":"Therapeutic efficacy and safety of umbilical cord mesenchymal stem cell transplantation for liver cirrhosis in Chinese population: a meta-analysis","volume":"42","author":"Sang","year":"2018","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.retram.2019.09.001_bib0330","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jcyt.2012.09.005","article-title":"Clinical analysis of the treatment of spinal cord injury with umbilical cord mesenchymal stem cells","volume":"15","author":"Liu","year":"2013","journal-title":"Cytotherapy"},{"key":"10.1016\/j.retram.2019.09.001_bib0335","doi-asserted-by":"crossref","first-page":"e3336","DOI":"10.1371\/journal.pone.0003336","article-title":"Transplantation of human umbilical mesenchymal stem cells from Wharton\u2019s jelly after complete transection of the rat spinal cord","volume":"3","author":"Yang","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.retram.2019.09.001_bib0340","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3727\/096368915X687796","article-title":"Continuous improvement after multiple mesenchymal stem cell transplantations in a patient with complete spinal cord injury","volume":"24","author":"Jarocha","year":"2015","journal-title":"Cell Transplant"},{"key":"10.1016\/j.retram.2019.09.001_bib0345","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12967-014-0253-7","article-title":"Clinical observation of umbilical cord mesenchymal stem cell transplantation in treatment for sequelae of thoracolumbar spinal cord injury","volume":"12","author":"Cheng","year":"2014","journal-title":"J Transl Med"},{"key":"10.1016\/j.retram.2019.09.001_bib0350","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13287-015-0271-2","article-title":"Biodistribution, migration and homing of systemically applied mesenchymal stem\/stromal cells","volume":"7","author":"Leibacher","year":"2016","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.retram.2019.09.001_bib0355","first-page":"3241","article-title":"Therapeutic effects of human umbilical cord mesenchymal stem cells transplantation on hypoxic ischemic encephalopathy","volume":"8","author":"Xie","year":"2016","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.retram.2019.09.001_bib0360","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1177\/0963689718786692","article-title":"Wharton\u2019s jelly-derived mesenchymal stem cell transplantation in a patient with hypoxic-ischemic encephalopathy: a pilot study","volume":"27","author":"Kabata\u015f","year":"2018","journal-title":"Cell Transplant"},{"key":"10.1016\/j.retram.2019.09.001_bib0365","first-page":"140","article-title":"Umbilical cord mesenchymal stem cells in neurological disorders: a clinical study","volume":"52","author":"Miao","year":"2015","journal-title":"Indian J Biochem Biophys"},{"key":"10.1016\/j.retram.2019.09.001_bib0370","first-page":"901","article-title":"Umbilical cord mesenchymal stem cell (UC-MSC) transplantations for cerebral palsy","volume":"10","author":"Dong","year":"2018","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.retram.2019.09.001_bib0375","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4103\/1673-5374.243723","article-title":"Safety of intrathecal injection of Wharton\u2019s jelly-derived mesenchymal stem cells in amyotrophic lateral sclerosis therapy","volume":"14","author":"Barczewska","year":"2019","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.retram.2019.09.001_bib0380","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1314709","article-title":"Proangiogenic features of mesenchymal stem cells and their therapeutic applications","volume":"2016","author":"Tao","year":"2016","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.retram.2019.09.001_bib0385","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/sctm.16-0484","article-title":"Concise review: mesenchymal stem cells in cardiovascular regeneration: emerging research directions and clinical applications","volume":"6","author":"Majka","year":"2017","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.retram.2019.09.001_bib0390","first-page":"100","article-title":"Myocardial regeneration strategy using Wharton\u2019s jelly mesenchymal stem cells as an off-the-shelf \u2018unlimited\u2019therapeutic agent: results from the acute myocardial infarction first-in-man study","volume":"11","author":"Musialek","year":"2015","journal-title":"Post\u0119py w Kardiol Interwencyjnej"},{"key":"10.1016\/j.retram.2019.09.001_bib0395","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.4238\/2015.April.10.11","article-title":"Clinical observation of umbilical cord mesenchymal stem cell treatment of severe systolic heart failure","volume":"14","author":"Zhao","year":"2015","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.retram.2019.09.001_bib0400","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12916-015-0399-z","article-title":"Intracoronary infusion of Wharton\u2019s jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trial","volume":"13","author":"Gao","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.retram.2019.09.001_bib0405","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/CIRCRESAHA.117.310712","article-title":"Safety and efficacy of the intravenous infusion of umbilical cord mesenchymal stem cells in patients with heart failure: a phase 1\/2 randomized controlled trial (RIMECARD trial [randomized clinical trial of intravenous infusion umbilical cord mesenchymal","volume":"121","author":"Bartolucci","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.retram.2019.09.001_bib0410","first-page":"240","article-title":"Lupus: an overview of the disease and management options","volume":"37","author":"Maidhof","year":"2012","journal-title":"Pharm Ther"},{"key":"10.1016\/j.retram.2019.09.001_bib0415","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1002\/art.27548","article-title":"Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus","volume":"62","author":"Sun","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.retram.2019.09.001_bib0420","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1186\/ar4520","article-title":"Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study","volume":"16","author":"Wang","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.retram.2019.09.001_bib0425","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.3727\/096368911X582769c","article-title":"Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 years of experience","volume":"22","author":"Wang","year":"2013","journal-title":"Cell Transplant"},{"key":"10.1016\/j.retram.2019.09.001_bib0430","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1007\/s10067-014-2754-4","article-title":"Allogeneic mesenchymal stem cell transplantation for lupus nephritis patients refractory to conventional therapy","volume":"33","author":"Gu","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.retram.2019.09.001_bib0435","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1089\/scd.2017.0029","article-title":"Human Wharton\u2019s jelly-derived stem cells display a distinct immunomodulatory and proregenerative transcriptional signature compared to bone marrow-derived stem cells","volume":"27","author":"Donders","year":"2018","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.retram.2019.09.001_bib0440","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.3727\/096368914X685104","article-title":"Human Wharton\u2019s jelly-derived stem cells display immunomodulatory properties and transiently improve rat experimental autoimmune encephalomyelitis","volume":"24","author":"Donders","year":"2015","journal-title":"Cell Transplant"},{"key":"10.1016\/j.retram.2019.09.001_bib0445","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.3727\/096368914X685005","article-title":"The potential of human umbilical cord-derived mesenchymal stem cells as a novel cellular therapy for multiple sclerosis","volume":"23","author":"Li","year":"2014","journal-title":"Cell Transplant"},{"key":"10.1016\/j.retram.2019.09.001_bib0450","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1590\/S0100-879X1998000100007","article-title":"Role of Th1 and Th2 cells in autoimmune demyelinating disease","volume":"31","author":"Nagelkerken","year":"1998","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.retram.2019.09.001_bib0455","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.3892\/etm.2017.4229","article-title":"Intravenous infusion umbilical cord-derived mesenchymal stem cell in primary immune thrombocytopenia: a two-year follow-up","volume":"13","author":"Wang","year":"2017","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.retram.2019.09.001_bib0460","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.stem.2012.02.005","article-title":"Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease","volume":"10","author":"Ranganath","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.retram.2019.09.001_bib0465","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000447458","article-title":"Mesenchymal stem\/stromal cells in regenerative medicine: can preconditioning strategies improve therapeutic efficacy","volume":"43","author":"Schaefer","year":"2016","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.retram.2019.09.001_bib0470","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1002\/stem.1976","article-title":"Hypoxic preconditioning of mesenchymal stromal cells induces metabolic changes, enhances survival, and promotes cell retention in vivo","volume":"33","author":"Beegle","year":"2015","journal-title":"Stem Cells"},{"key":"10.1016\/j.retram.2019.09.001_bib0475","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1634\/stemcells.2007-1104","article-title":"Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells","volume":"26","author":"Rosova","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.retram.2019.09.001_bib0480","doi-asserted-by":"crossref","first-page":"e2395","DOI":"10.1038\/cddis.2016.310","article-title":"Hypoxia-induced expression of cellular prion protein improves the therapeutic potential of mesenchymal stem cells","volume":"7","author":"Han","year":"2016","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.retram.2019.09.001_bib0485","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/bjh.12545","article-title":"Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid-refractory, grade III-IV acute graft-versus-host disease","volume":"163","author":"Ball","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.retram.2019.09.001_bib0490","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.3390\/ijms19051503","article-title":"The effect of human mesenchymal stem cells derived from Wharton\u2019s jelly in spinal cord injury treatment is dose-dependent and can be facilitated by repeated application","volume":"19","author":"Krupa","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.retram.2019.09.001_bib0495","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1097\/TP.0000000000001773","article-title":"Biodistribution of liver-derived mesenchymal stem cells after peripheral injection in a hemophilia A patient","volume":"101","author":"Sokal","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.retram.2019.09.001_bib0500","doi-asserted-by":"crossref","first-page":"I150","DOI":"10.1161\/CIRCULATIONAHA.104.526749","article-title":"Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials","volume":"112","author":"Hou","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.retram.2019.09.001_bib0505","article-title":"Maximum efficacy of mesenchymal stem cells in rat model of renal ischemia-reperfusion injury: renal artery administration with optimal numbers","volume":"9","author":"Cai","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.retram.2019.09.001_bib0510","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s10561-014-9420-6","article-title":"Monitoring the biology stability of human umbilical cord-derived mesenchymal stem cells during long-term culture in serum-free medium","volume":"15","author":"Chen","year":"2014","journal-title":"Cell Tissue Bank"},{"key":"10.1016\/j.retram.2019.09.001_bib0515","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1161\/CIRCRESAHA.110.239848","article-title":"Malignant tumor formation after transplantation of short-term cultured bone marrow mesenchymal stem cells in experimental myocardial infarction and diabetic neuropathy","volume":"108","author":"Jeong","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.retram.2019.09.001_bib0520","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1634\/stemcells.2005-0403","article-title":"Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation","volume":"24","author":"Miura","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.retram.2019.09.001_bib0525","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7012692","article-title":"Experimental strategies of mesenchymal stem cell propagation: adverse events and potential risk of functional changes","volume":"2019","author":"Drela","year":"2019","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.retram.2019.09.001_bib0530","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2174\/1875043501104010095","article-title":"Cardiac differentiation of human Wharton\u2019s jelly stem cells - experimental comparison of protocols","volume":"4","author":"Hollweck","year":"2011","journal-title":"Open Tissue Eng Regen Med J"},{"key":"10.1016\/j.retram.2019.09.001_bib0535","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2147\/JIR.S121994","article-title":"Activation, homing, and role of the mesenchymal stem cells in the inflammatory environment","volume":"9","author":"Zachar","year":"2016","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.retram.2019.09.001_bib0540","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4252\/wjsc.v10.i5.43","article-title":"Stem cells as delivery vehicles for regenerative medicine-challenges and perspectives","volume":"10","author":"Labusca","year":"2018","journal-title":"World J Stem Cells"},{"key":"10.1016\/j.retram.2019.09.001_bib0545","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1080\/10717544.2017.1375580","article-title":"Maximized nanodrug-loaded mesenchymal stem cells by a dual drug-loaded mode for the systemic treatment of metastatic lung cancer","volume":"24","author":"Yao","year":"2017","journal-title":"Drug Deliv"},{"key":"10.1016\/j.retram.2019.09.001_bib0550","first-page":"6","article-title":"Mesenchymal stem cells as delivery vectors for anti-tumor therapy","volume":"2","author":"Li","year":"2015","journal-title":"Stem Cell Investig"},{"key":"10.1016\/j.retram.2019.09.001_bib0555","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bgm.2015.06.001","article-title":"Human platelet lysate enhances the proliferation of Wharton\u2019s jelly-derived mesenchymal stem cells","volume":"7","author":"Antoninus","year":"2015","journal-title":"Biomarkers Genomic Med"},{"key":"10.1016\/j.retram.2019.09.001_bib0560","doi-asserted-by":"crossref","first-page":"54","DOI":"10.15283\/ijsc.2015.8.1.54","article-title":"New strategies for overcoming limitations of mesenchymal stem cell-based immune modulation","volume":"8","author":"Kim","year":"2015","journal-title":"Int J Stem Cells"},{"key":"10.1016\/j.retram.2019.09.001_bib0565","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1161\/CIRCRESAHA.117.312486","article-title":"Preclinical studies of stem cell therapy for heart disease","volume":"122","author":"Tompkins","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.retram.2019.09.001_bib0570","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.3892\/etm.2016.3724","article-title":"Safety and therapeutic effect of mesenchymal stem cell infusion on moderate to severe ulcerative colitis","volume":"12","author":"Hu","year":"2016","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.retram.2019.09.001_bib0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.eats.2017.08.055","article-title":"Cartilage repair in the knee using umbilical cord Wharton\u2019s jelly\u2013derived mesenchymal stem cells embedded onto collagen scaffolding and implanted under dry arthroscopy","volume":"7","author":"Sadlik","year":"2018","journal-title":"Arthrosc Tech"}],"container-title":["Current Research in Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318619300364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318619300364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:38:49Z","timestamp":1762821529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452318619300364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":115,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S2452318619300364"],"URL":"https:\/\/doi.org\/10.1016\/j.retram.2019.09.001","relation":{},"ISSN":["2452-3186"],"issn-type":[{"value":"2452-3186","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics and clinical applications of Wharton\u2019s jelly-derived mesenchymal stromal cells","name":"articletitle","label":"Article Title"},{"value":"Current Research in Translational Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.retram.2019.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}